Crizotinib-xalkori (200 mg & 250 mg)

Pfizer

“Crizotinib” is the Drug / Molecule content in “Xalkori”. It has an aminopyridine structure, and functions as a protein kinase inhibitor Crizotinib blocks an enzyme called anaplastic lymphoma kinase (ALK). Blocking this enzyme stops the growth of cells.

Indication

Crizotinib is used  for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in a gene called ALK (anaplastic lymphoma kinase).

Note

Precaution

  • Crizotinib is a prescription drug and should be used under proper medical guidance and advice.
  • Do not receive any kind of immunization or vaccination without your doctor’s approval while taking Crizotinib.